TO Advance a Promising, Small-Molecule Compound CRS0540 to IND Filing and Through Phase I Clinical Studies
Contract Overview
Contract Amount: $20,477,990 ($20.5M)
Contractor: Crestone, Inc.
Awarding Agency: Department of Health and Human Services
Start Date: 2020-07-01
End Date: 2026-08-19
Contract Duration: 2,240 days
Daily Burn Rate: $9.1K/day
Official Description: TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.
Place of Performance
Location: Colorado, 80301
State: Colorado Government Spending